LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.12 | 21.74 | 2779 | 6211 | 0.4474 | 0.8122 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.12 | 21.74 | 10280 | 6211 | 1.6549 | 1.1274 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.09 | 21.74 | 151 | 6201 | 0.0244 | 0.2682 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.09 | 21.74 | 10885 | 6201 | 1.7553 | 1.1428 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.09 | 21.74 | 1764 | 6201 | 0.2845 | 0.7143 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.09 | 21.74 | 10364 | 6201 | 1.6713 | 1.1300 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.06 | 21.74 | 65 | 6152 | 0.0106 | 0.1439 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.06 | 21.74 | 10997 | 6152 | 1.7875 | 1.1478 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.06 | 21.74 | 1389 | 6152 | 0.2258 | 0.6660 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 84.06 | 21.74 | 10329 | 6152 | 1.6789 | 1.1314 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.03 | 21.74 | 49 | 6155 | 0.0080 | 0.1049 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.03 | 21.74 | 11219 | 6155 | 1.8226 | 1.1530 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.03 | 21.74 | 820 | 6155 | 0.1332 | 0.5615 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 86.03 | 21.74 | 10301 | 6155 | 1.6735 | 1.1305 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.00 | 21.74 | 26 | 6081 | 0.0043 | 0.0223 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.00 | 21.74 | 11373 | 6081 | 1.8701 | 1.1601 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.00 | 21.74 | 517 | 6081 | 0.0850 | 0.4768 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.00 | 21.74 | 10248 | 6081 | 1.6851 | 1.1326 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.97 | 21.74 | 23 | 6084 | 0.0038 | 0.0070 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.97 | 21.74 | 11572 | 6084 | 1.9019 | 1.1646 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.97 | 21.74 | 222 | 6084 | 0.0365 | 0.3309 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 89.97 | 21.74 | 10257 | 6084 | 1.6858 | 1.1327 | MN20160310_N01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.94 | 21.74 | 20 | 6121 | 0.0033 | -0.0102 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.94 | 21.74 | 11764 | 6121 | 1.9216 | 1.1672 | MN20160310_N01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 91.94 | 21.74 | 56 | 6121 | 0.0091 | 0.1233 | MN20160310_N01 | J07 |